News

Posted On: 04/09/2007

Xcellerex Appoints Chickosky as Chief Operating Officer

PharmaManufacturing.com

Xcellerex Inc., which provides manufacturing services and systems for biotherapeutics and vaccines based on proprietary, disposable component technology, on Apr. 9 announced the appointment of John Chickosky to the newly created position of chief operating officer. Chickosky joins Xcellerex with more than 20 years of senior management experience in life science technology companies including Kendro Laboratory Products, CARR Separations, and Sepracor.

"John brings a wealth of experience and an outstanding track record in marketing, sales, corporate development and building successful organizations to commercialize advanced life science technologies," said Mike Masterson, Xcellerex's chief executive officer. "His appointment comes at a key point in the evolution of the company to commercialize its enabling and proprietary disposable biomanufacturing systems. We are both growing our contract manufacturing services business using these systems and are now poised to accelerate the commercialization of our disposable bioreactor products and FlexFactory integrated manufacturing system for vaccines and biotherapeutics."

Previously, Chickosky held senior positions at life science equipment companies, including at Kendro Laboratory Products (now part of Thermo Electron), where he was vice president, Global Bioprocessing and Drug Discovery Sales, and at CARR Separations, where he was senior vice president, Sales and Marketing. Prior to CARR, he served as vice president, Sales and Marketing at AquaAir, Inc. and at Sepracor as vice president, Marketing and vice president, Business Development. He holds a Bachelor of Science degree in Electrical Engineering and Computer Science from Santa Clara University, and an MBA from St. Mary's College (Calif.).